Pathological microtubule dynamics in Parkinson’s disease: Mechanisms and therapeutic implications
Advances in Protein Chemistry and Structural Biology · 2026
DOI: 10.1016/bs.apcsb.2025.10.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2026. Verfasst von Kirti Baghel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Delhi South Campus, New Delhi, India. Hauptthemen laut MEDLINE: Parkinson Disease, Microtubules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily marked by the degeneration of dopaminergic neurons in the substantia nigra and the pathological accumulation of misfolded α-synuclein in Lewy bodies. This chapter explores the underrecognized role of microtubule (MT) dysregulation in PD pathogenesis, linking disruptions in cytoskeletal integrity to impaired axonal transport and neuronal survival. The fundamental biology of MTs, their dynamics, and their regulation by motor proteins and associated proteins like MT-associated proteins (MAPs), tau, and gamma-tubulin complexes. Special attention is given to how mutations linked to PD, such as those in SNCA (α-synuclein), Parkin, PINK1 (PTEN-induced kinase 1), and LRRK2 (leucine-rich repeat kinase 2), lead to MT destabilization, impaired mitophagy, and disruptions in axonal transport. A self-perpetuating cycle of MT disruption and α-synuclein aggregation is proposed, resulting in synaptic failure and dopaminergic neuron loss. The chapter also evaluates emerging therapeutic strategies targeting MT stabilization, including LRRK2 inhibitors, MT-stabilizing agents like Epothilone D, and approaches to modulate α-synuclein aggregation. Challenges such as the blood-brain barrier, off-target effects of MT-targeting drugs, and patient-specific variability in drug response are critically discussed. The future directions include CRISPR-Cas9-based gene therapies and personalized medicine, emphasizing the need for a deeper understanding of PD-related molecular pathways. This comprehensive overview highlights MT dynamics not just as collateral damage but as a central element in PD pathology, offering novel insights into potential avenues for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Delhi South Campus, New Delhi, India.
- Department of Biochemistry, Central University of Rajasthan, Kishangarh, Ajmer, Rajasthan, India.
- Department of Biochemistry, University of Delhi South Campus, New Delhi, India. Electronic address: vkp@south.du.ac.in.
Zitieren
APA
Baghel, K., Dubey, A. K., Singh, S., & Prajapati, V. K. (2026). Pathological microtubule dynamics in Parkinson’s disease: Mechanisms and therapeutic implications. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2025.10.019
Vancouver
Baghel K, Dubey AK, Singh S, Prajapati VK. Pathological microtubule dynamics in Parkinson’s disease: Mechanisms and therapeutic implications. Advances in Protein Chemistry and Structural Biology. 2026. doi:10.1016/bs.apcsb.2025.10.019
BibTeX
@article{Baghel2026,
author = {Baghel, Kirti and Dubey, Ateendra Kumar and Singh, Satyendra and Prajapati, Vijay Kumar},
title = {Pathological microtubule dynamics in Parkinson’s disease: Mechanisms and therapeutic implications},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2026},
doi = {10.1016/bs.apcsb.2025.10.019}
}
EUVIMED